|
Schally, A V; Szepeshazi, K; Nagy, A et al. (2004) New approaches to therapy of cancers of the stomach, colon and pancreas based on peptide analogs. Cell Mol Life Sci 61:1042-68
|
|
Schally, A V; Comaru-Schally, A M; Nagy, A et al. (2001) Hypothalamic hormones and cancer. Front Neuroendocrinol 22:248-91
|
|
Szepshazi, K; Halmos, G; Groot, K et al. (1994) Combination treatment of nitrosamine-induced pancreatic cancers in hamsters with analogs of LH-RH and a bombesin/GRP antagonist. Int J Pancreatol 16:141-9
|
|
Qin, Y; Ertl, T; Cai, R Z et al. (1994) Inhibitory effect of bombesin receptor antagonist RC-3095 on the growth of human pancreatic cancer cells in vivo and in vitro. Cancer Res 54:1035-41
|
|
Pinski, J; Schally, A V; Halmos, G et al. (1994) Somatostatin analogues and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of human glioblastomas in vitro and in vivo. Cancer Res 54:5895-901
|
|
Radulovic, S; Schally, A V; Reile, H et al. (1994) Inhibitory effects of antagonists of bombesin/gastrin releasing peptide (GRP) and somatostatin analog (RC-160) on growth of HT-29 human colon cancers in nude mice. Acta Oncol 33:693-701
|
|
Halmos, G; Pinski, J; Szoke, B et al. (1994) Characterization of bombesin/gastrin-releasing peptide receptors in membranes of MKN45 human gastric cancer. Cancer Lett 85:111-8
|
|
Pinski, J; Halmos, G; Yano, T et al. (1994) Inhibition of growth of MKN45 human gastric-carcinoma xenografts in nude mice by treatment with bombesin/gastrin-releasing-peptide antagonist (RC-3095) and somatostatin analogue RC-160. Int J Cancer 57:574-80
|
|
O'Byrne, K J; Halmos, G; Pinski, J et al. (1994) Somatostatin receptor expression in lung cancer. Eur J Cancer 30A:1682-7
|
|
Pinski, J; Schally, A V; Halmos, G et al. (1994) Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice. Br J Cancer 70:886-92
|
Showing the most recent 10 out of 50 publications
